Developer of genetic analysis tools intended to be used for the research and diagnostic markets.
Diagnostic Equipment📍 San Diego, CAFounded 2017
Current Valuation
$1.0B
as of 2024-Q3
UNICORN
Developer of genetic analysis tools intended to be used for the research and diagnostic markets.
Company Profile
Founded
2017
HQ
San Diego, CA
Employees
440
Total Raised
$683.3M
Last Round
Series D — $277M (Jul 2024)
IPO Status
private
Fundraising Status
Series D · $277M · 2y 1mo ago
privateTotal raised $683.3M
Secondary Market
Implied price / share
$4
Last round price / share
$7.84
vs last round
-49.0%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$277M
Jul 2024
—
$1.0B
BiotechnologyGeneticsHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q3. Refreshed quarterly.